Edik M. Blais

1.8k total citations · 1 hit paper
34 papers, 1.1k citations indexed

About

Edik M. Blais is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Edik M. Blais has authored 34 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Cancer Research and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Edik M. Blais's work include Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (17 papers) and Neuroendocrine Tumor Research Advances (7 papers). Edik M. Blais is often cited by papers focused on Pancreatic and Hepatic Oncology Research (20 papers), Cancer Genomics and Diagnostics (17 papers) and Neuroendocrine Tumor Research Advances (7 papers). Edik M. Blais collaborates with scholars based in United States, Austria and Colombia. Edik M. Blais's co-authors include Michael J. Pishvaian, Andrew Hendifar, Emanuel F. Petricoin, Subha Madhavan, Davendra Sohal, Lynn M. Matrisian, Vincent Chung, Jason A. Papin, Emily E. Lyons and Jonathan R. Brody and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Edik M. Blais

27 papers receiving 1.1k citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial

2020 327 citations Michael J. Pishvaian, Edik M. Blais et al. The Lancet Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Edik M. Blais United States	16	681	499	378	180	121	34	1.1k
Eva Obermayr Austria	15	508 0.7×	481 1.0×	327 0.9×	144 0.8×	115 1.0×	44	953
Jiangdong Qiu China	14	525 0.8×	489 1.0×	580 1.5×	150 0.8×	113 0.9×	22	1.2k
Hongjun Gao China	19	557 0.8×	348 0.7×	478 1.3×	449 2.5×	107 0.9×	72	1.1k
Andreas-Claudius Hoffmann Germany	22	584 0.9×	440 0.9×	574 1.5×	298 1.7×	61 0.5×	53	1.3k
Yanwei Shen China	16	400 0.6×	483 1.0×	636 1.7×	199 1.1×	58 0.5×	39	1.2k
Hien Dang United States	15	376 0.6×	268 0.5×	479 1.3×	92 0.5×	70 0.6×	24	1.0k
Marion T. Weigel Germany	16	338 0.5×	275 0.6×	481 1.3×	119 0.7×	45 0.4×	27	1.1k
Maarten W. Nijkamp Netherlands	17	419 0.6×	248 0.5×	346 0.9×	126 0.7×	90 0.7×	51	1.1k
Shane R. Stecklein United States	16	471 0.7×	356 0.7×	374 1.0×	130 0.7×	28 0.2×	52	934

Countries citing papers authored by Edik M. Blais

Since Specialization

Citations

This map shows the geographic impact of Edik M. Blais's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edik M. Blais with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edik M. Blais more than expected).

Fields of papers citing papers by Edik M. Blais

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edik M. Blais. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edik M. Blais. The network helps show where Edik M. Blais may publish in the future.

Co-authorship network of co-authors of Edik M. Blais

This figure shows the co-authorship network connecting the top 25 collaborators of Edik M. Blais. A scholar is included among the top collaborators of Edik M. Blais based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edik M. Blais. Edik M. Blais is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Xing, Shipei, et al.. (2026). Navigating the conjugated metabolome. bioRxiv (Cold Spring Harbor Laboratory).

Levi, Abrahm, Edik M. Blais, Gillian Gresham, et al.. (2025). Clinical outcomes and molecular characteristics of lung-only and liver-only metastatic pancreatic cancer: results from a real-world evidence database. The Oncologist. 30(3).

Baldelli, Elisa, Edik M. Blais, Claudius Mueller, et al.. (2024). Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort. British Journal of Cancer. 131(9). 1543–1554. 2 indexed citations

Roa‐Peña, Lucia, Sruthi Babu, Emanuel F. Petricoin, et al.. (2024). Keratin 17 is a prognostic and predictive biomarker in pancreatic ductal adenocarcinoma. American Journal of Clinical Pathology. 162(3). 314–326. 1 indexed citations

Blais, Edik M., Steven J. Cohen, David Halverson, et al.. (2023). Association of Pancreatic Adenocarcinoma Location With DNA Damage Response Status and Response to Platinum-Based Therapy. JCO Precision Oncology. 7(7). e2200648–e2200648. 1 indexed citations

Hendifar, Andrew, Edik M. Blais, Brian M. Wolpin, et al.. (2021). Retrospective Case Series Analysis ofRAFFamily Alterations in Pancreatic Cancer: Real-World Outcomes From Targeted and Standard Therapies. JCO Precision Oncology. 5(5). 1325–1338. 22 indexed citations

Hendifar, Andrew, Edik M. Blais, Dzung Thach, et al.. (2020). Comprehensive analysis of KRAS variants in patients (pts) with pancreatic cancer (PDAC): Clinical/molecular correlations and real-world outcomes across standard therapies.. Journal of Clinical Oncology. 38(15_suppl). 4641–4641. 7 indexed citations

Pishvaian, Michael J., Edik M. Blais, Jonathan R. Brody, et al.. (2020). Overall survival in patients with pancreatic cancer receiving matched therapies following molecular profiling: a retrospective analysis of the Know Your Tumor registry trial. The Lancet Oncology. 21(4). 508–518. 327 indexed citations breakdown →

Lowder, Cinthya Y., Austin Goetz, Talar Tatarian, et al.. (2020). A step towards personalizing next line therapy for resected pancreatic and related cancer patients: A single institution's experience. Surgical Oncology. 33. 118–125. 3 indexed citations

10.

Brar, Gagandeep, Edik M. Blais, R Joseph Bender, et al.. (2019). Multi-omic molecular comparison of primary versus metastatic pancreatic tumours. British Journal of Cancer. 121(3). 264–270. 23 indexed citations

11.

Blais, Edik M., Bonnie V. Dougherty, Kalyan C. Vinnakota, et al.. (2019). Genome-Scale Characterization of Toxicity-Induced Metabolic Alterations in Primary Hepatocytes. Toxicological Sciences. 172(2). 279–291. 15 indexed citations

12.

Matrisian, Lynn M., Edik M. Blais, Emily E. Lyons, et al.. (2019). Precision Oncology for Pancreatic Cancer across the United States: the Know Your Tumor ® experience. Annals of Oncology. 30. vi30–vi30.

13.

McGrath, John S., Carlos Honrado, John H. Moore, et al.. (2019). Electrophysiology-based stratification of pancreatic tumorigenicity by label-free single-cell impedance cytometry. Analytica Chimica Acta. 1101. 90–98. 53 indexed citations

14.

Pishvaian, Michael J., R Joseph Bender, Lola Rahib, et al.. (2018). Molecular Profiling of Patients with Pancreatic Cancer: Initial Results from the Know Your Tumor Initiative. Clinical Cancer Research. 24(20). 5018–5027. 149 indexed citations

15.

Dougherty, Bonnie V., Edik M. Blais, Glynis L. Kolling, et al.. (2018). A simplified metabolic network reconstruction to promote understanding and development of flux balance analysis tools. Computers in Biology and Medicine. 105. 64–71. 19 indexed citations

16.

Blais, Edik M., Bonnie V. Dougherty, Glynis L. Kolling, et al.. (2017). Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions. Nature Communications. 8(1). 14250–14250. 140 indexed citations

17.

Newhook, Timothy E., Edik M. Blais, James Lindberg, et al.. (2014). A Thirteen-Gene Expression Signature Predicts Survival of Patients with Pancreatic Cancer and Identifies New Genes of Interest. PLoS ONE. 9(9). e105631–e105631. 27 indexed citations

18.

Blais, Edik M., Arvind K. Chavali, & Jason A. Papin. (2013). Linking Genome-Scale Metabolic Modeling and Genome Annotation. Methods in molecular biology. 985. 61–83. 7 indexed citations

19.

Tilghman, Robert W., Edik M. Blais, Catharine Cowan, et al.. (2012). Matrix Rigidity Regulates Cancer Cell Growth by Modulating Cellular Metabolism and Protein Synthesis. PLoS ONE. 7(5). e37231–e37231. 65 indexed citations

20.

Burnett, Lindsey A., Edik M. Blais, Jashvant D. Unadkat, et al.. (2010). Testicular Expression of Adora3i2 in Adora3 Knockout Mice Reveals a Role of Mouse A3Ri2 and Human A3Ri3 Adenosine Receptors in Sperm*. Journal of Biological Chemistry. 285(44). 33662–33670. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact